J&J Vision Presents Data Validating Improved Surgical Outcomes and Surgeon Satisfaction at ASCRS

Johnson & Johnson Vision will present and/or support 46 company-sponsored and investigator-led studies evaluating innovations and outcomes across its surgical portfolio at the 2022 American Society of Cataract and Refractive Surgery (ASCRS) annual meeting in Washington, DC, April 22-26. A complete listing of abstracts and events can be found on the ASCRS website. .

"We take an outcomes-led approach to innovation, incorporating input from surgeons to develop evidenced-based solutions that help them improve their patients' sight and quality of life,” said Rajesh Rajpal, MD, Chief Medical Officer and Global Head of Clinical and Medical Affairs, Johnson & Johnson Vision. "At ASCRS this year, we’re thrilled to present a robust slate of data reinforcing the technological advances and improved outcomes offered by our TECNIS family of IOLs and our innovative surgical systems.”

At the meeting, Johnson & Johnson Vision will also introduce the next-gen TearScience Activator Clear, a new Activator for the TearScience LipiFlow Thermal Pulsation System that provides greater treatment precision, created with the environment in mind. Surgeons can view this new technology at the Johnson & Johnson Vision booth (#1837), which will also feature some of the latest innovations in cataract care, including the Tecnis Synergy IOL, Tecnis Eyhance IOL, and Veritas Vision System. Additional information can be found at jnjvisionpro.com/join-us-ascrs-2022.

Highlights of Data to be Presented at the Meeting

Evidence Shows Wide Range of Functional Binocular Vision with TECNIS Synergy IOL***

Many people who have cataracts also experience presbyopia. Cataract surgery provides a unique opportunity to address the condition without an additional procedure. Data on the TECNIS Synergy IOL, a breakthrough lens designed to deliver a wider* range of continuous vision**,[1] will show that it provided a wide range of functional binocular vision, from distance to intermediate, to near (33cm).

1. Paper Presentation: “Visual Outcomes of New Continuous Range of Vision Presbyopia-Correcting Intraocular Lens Under Photopic Light Conditions.” De Rojas J. (Abstract #80844). Monday, April 25, 2022, 10:05 AM - 10:10 AM, WEWCC - Level 1, 143C.

Evidence Shows Tecnis Eyhance IOLs Improve Visual Acuity and Provide Excellent Rotational Stability

The Tecnis Eyhance IOLs are a next-generation monofocal lens created to provide high-quality vision from day to night, including for patients with astigmatism, delivering not only high-quality distance vision, but also better low-light image contrast.[2],[3]Data to be presented shows that the Tecnis IOLs improve visual acuity, with the Toric II lens providing excellent rotational stability. And with contrast sensitivity being an important element of vision that impacts health related quality of life and safety,[4] an additional study supports considering image contrast differences when selecting an IOL.

1. Paper Presentation: “Visual Acuity Outcomes Post-Implantation of a New Monofocal IOL Using Different Target Refractions.” Sandoval H. (Abstract #82285). Saturday, April 23, 2022, 3:40 PM - 3:45 PM, WEWCC - Level 1, 144A.
2. Paper Presentation: “Tolerance to Induced Astigmatism: Comparison of Standard and Enhanced Monofocal IOLs.” Rocha K. (Abstract #82792). Sunday, April 24, 2022, 1:35 PM - 1:40 PM, WEWCC - Level 1, 144A.
3. Paper Presentation: “Subjective and Objective Assessments of Performance of a Toric Intraocular Lens with Modified Haptics.” Quesada G. (Abstract #83298. Monday, April 25, 2022, 10:46 AM - 10:51 AM, WEWCC - Level 1, 144A.
4. Paper Presentation: “Objective Metrics for Quantifying Monofocal and Presbyopia-Correcting IOL Contrast Performance.” Chang D. (Abstract #84997). ASCRS Electronic Posters (On-Demand).

Studies Show Good Visual Acuity Outcomes and High Rates of Surgeon Satisfaction with VERITAS Vision System and Patient Preference for LASIK over SMILE

When choosing an ocular surgical technology, understanding surgeon and patient experience may provide helpful context for decision-making. Data to be presented shows that surgeons achieve good visual acuity outcomes for their patients and report high satisfaction with the overall performance of the Veritas Vision System and its new swivel handpiece, a next-generation phacoemulsification (phaco) system designed to address patient safety, surgeon efficiency and comfort. In a second study evaluating patient-reported quality of vision in LASIK and SMILE procedures, more patients preferred the vision provided by LASIK, with similar rates reported of adverse visual symptoms.

1. Paper Presentation: “Evaluation of Surgeon Satisfaction and Visual Outcomes of a Dual Mode Phacoemulsification System.” Quesada G. (Abstract #82436). Monday, April 25, 2022, 8:28 AM - 8:33 AM, WEWCC - Level 1, 143B.
2. Paper Presentation: “Patient-Reported Quality of Vision in a Prospective Randomized Trial Comparing LASIK and SMILE.” Ma K. (Abstract #83533). Monday, April 25, 2022, 10:28 AM - 10:33 AM, WEWCC - Level 1, 143B.

All educational content of the ASCRS Annual Meeting is planned by its program committee, and ASCRS does not endorse, promote, approve, or recommend the use of any products, devices, or services.